PROTON PUMP INHIBITORS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Proton Pump Inhibitors Market, By Type (Omeprazole, Pantaprazole, Rabeprazole, Dexlansoprazole, lansoprazole, Others), By Disease Indication (Ulcers, Gastroesophageal Reflux Disease, Others), By Dosage Form (Tablet, Capsules, Injection, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In: 12 Mar, 2026
Code: CMI4225
Page number: 152
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Type
  - Market Snapshot, By Disease Indication
  - Market Snapshot, By Dosage Form
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter’s Analysis
Global Proton Pump Inhibitors Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
Global Proton Pump Inhibitors Market, By Type, 2021 – 2033, (USD Bn)
- Overview
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Omeprazole
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Pantaprazole
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Rabeprazole
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Dexlansoprazole
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Lansoprazole
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
Global Proton Pump Inhibitors Market, By Disease Indication, 2021 – 2033, (USD Bn)
- Overview
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Ulcers
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Gastroesophageal Reflux Disease
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
Global Proton Pump Inhibitors Market, By Dosage Form, 2021 – 2033, (USD Bn)
- Overview
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Tablet
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Capsules
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Injection
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
Global Proton Pump Inhibitors Market, By Dosage Form, 2021 – 2033, (USD Bn)
- Overview
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Hospital Pharmacies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Retail Pharmacies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Online Pharmacies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
Global Proton Pump Inhibitors Market, By Region, 2021 – 2033, (USD Bn)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Region, 2022–2033
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - AstraZeneca
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Pfizer
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Takeda Pharmaceutical Company Limited
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Novartis AG
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Procter & Gamble
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Johnson & Johnson
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - GlaxoSmithKline plc
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Bayer AG
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Eisai Co., Ltd.
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Merck & Co., Inc.
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Dr. Reddy’s Laboratories Ltd.
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Sanofi
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Teva Pharmaceutical Industries Ltd.
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Mylan N.V.
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Sun Pharmaceutical Industries Ltd.
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Allergan, Inc.
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Cadila Pharmaceuticals
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Daiichi Sankyo Company, Limited
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Perrigo Company PLC.
    - Company Highlights
    - Disease Indication Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
Reference and Research Methodology
- References
- Research Methodology
- About us and Sales Contact

*Browse 32 market data tables and 28 figures on "Proton Pump Inhibitors Market” - Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now